Table of Contents
The global medical devices market could reach $817.78 billion by 2031. Yet new European market data, WHO guidance and OECD research reveal why medical equipment spending, functionality and real hospital capacity are not the same thing.
A hospital announces a major medical technology investment. Its new hospital equipment plan includes diagnostic systems, electric patient beds, transport stretchers and specialized treatment stations.
The purchases are completed. The equipment arrives. The project is celebrated.
But six months later, the hospital discovers a more complicated reality.
Some devices are awaiting commissioning. Others require maintenance. Certain departments have equipment they rarely use, while others cannot access the devices they need. As the questions in Optium's hospital bed lifespan and replacement analysis illustrate, owning an asset does not necessarily mean that it remains ready for clinical use.
Other newly equipped patient positions cannot operate at their intended capacity because clinical staffing is insufficient. That distinction is central to our research on the projected global nursing shortage of 4.1 million by 2030.
The hospital owns more equipment than before.
But has it actually become more capable?
This hypothetical scenario captures a question that deserves far more attention as the medical technology industry expands.
According to MarketsandMarkets, the global medical devices market was valued at approximately $544.15 billion in 2025 and is projected to grow from $580.79 billion in 2026 to $817.78 billion by 2031.
That represents nearly $237 billion in additional forecast annual market value.
Yet the latest 118 hospital bed statistics and healthcare capacity indicators demonstrate why the relationship between equipment inventories, staffed capacity, patient demand and clinical infrastructure is much more complicated than a purchasing total.
Meanwhile, emerging smart hospital bed technologies are creating new opportunities to measure equipment status, movement, maintenance and utilization.
The technology industry's financial growth is remarkable.
But it raises an even more consequential question:
If the world spends hundreds of billions of dollars more on medical devices, how much of that spending will become healthcare capacity that patients can actually use?
Three important sources help us examine that question.
First, MarketsandMarkets forecasts a global medical devices market approaching $818 billion by 2031.
Second, MedTech Europe's October 2026 Facts & Figures report reveals that Europe's medical technology market grew by just 1.8% in 2025, compared with a reported ten-year average of 5.6%.
Third, the World Health Organization's September 2026 From Purchase to Functionality briefing argues that acquiring devices is insufficient unless they remain appropriate, safe, available and functional.
These reports examine different dimensions of healthcare technology.
Together, they suggest why industry growth, hospital investment and clinical service capacity should never be treated as interchangeable measures.
This article explores the evidence behind the $818 billion forecast, compares the latest European market statistics, examines international equipment utilization data and introduces a practical framework for connecting procurement with operational readiness.
1. Quick Answer: Does a Growing Medical Devices Market Mean Better Healthcare?
Not automatically. Medical device market growth can support innovation and healthcare expansion, but increased equipment spending alone does not prove that access, clinical quality or patient outcomes have improved.
A medical device must be appropriate for a clinical need, installed correctly, operated by qualified personnel, maintained, supported by the necessary infrastructure and available when required.
Market revenue measures an industry's financial activity.
Healthcare capacity measures something different.
For example:
A purchased hospital bed is not necessarily a staffed patient-care position.
A functioning MRI scanner does not establish whether imaging is accessible or appropriately prescribed.
A new dialysis chair does not independently create additional treatment capacity.
A fully equipped emergency department does not eliminate patient-flow bottlenecks.
A modern medical device does not remain useful indefinitely without maintenance and supporting resources.
The WHO's technology lifecycle guidance emphasizes appropriate procurement, maintenance, health technology management and sustained functionality.
The OECD's comparative diagnostic technology data similarly demonstrates why device availability and utilization should be evaluated separately.
For hospital leaders, the practical conclusion is straightforward:
The goal is not simply to purchase more medical equipment. It is to maximize the reliable delivery of appropriate healthcare using suitable equipment.
2. The $818 Billion Medical Devices Market: Seven Figures That Explain the Forecast
Before drawing conclusions about healthcare, we need to understand what the industry forecast actually measures.
$544.15 billion: estimated global market value in 2025
MarketsandMarkets estimates that the global medical devices market reached approximately $544.15 billion in 2025.
This is the research provider's historical base-year market estimate.
It includes numerous medical technology categories.
It is not an estimate of worldwide spending on hospital furniture alone.
$580.79 billion: projected market size in 2026
The same research projects a 2026 global medical devices market value of $580.79 billion.
As of October 2026, that figure should be understood as the report's annual estimate or forecast rather than a finalized worldwide accounting total.
$817.78 billion: projected market size in 2031
The forecast reaches $817.78 billion by 2031.
For headlines, this can reasonably be rounded to $818 billion.
However, the published precision should be preserved when presenting the original research.
The figure remains a projection, not a guaranteed outcome.
$236.99 billion: projected increase in annual market value
Subtracting the 2026 forecast from the 2031 forecast gives:
$817.78 billion − $580.79 billion = $236.99 billion.
That is an approximately 40.8% increase relative to the 2026 estimate.
This calculation describes the difference between forecast annual market values.
It does not mean governments have committed another $236.99 billion to hospital construction.
It is not the cumulative value of all medical devices purchased between 2026 and 2031.
7.1%: projected compound annual growth
MarketsandMarkets estimates a compound annual growth rate of 7.1% over the 2026–2031 forecast period.
This represents the annualized growth implied by the forecast endpoints.
It does not imply that every country, company or product segment will grow by exactly 7.1% each year.
38.4%: North America's estimated share in 2025
The report identifies North America as the largest regional medical devices market in 2025, with an estimated 38.4% share.
That is a share of monetary market value.
It should not be confused with the region's share of the world's patients, medical equipment units or unmet healthcare needs.
20.0%: in vitro diagnostics' estimated market share
In vitro diagnostics represented the largest device-type segment in the report's 2025 estimates, with a 20.0% share.
This matters because the global medical devices industry covers products with dramatically different applications.
A laboratory diagnostic device, cardiac implant, surgical instrument, hospital bed and patient stretcher cannot be analyzed as interchangeable equipment.
The $818 billion forecast covers a broad medical technology market. It is not a market-size forecast specifically for hospital beds, stretchers, dialysis chairs or clinical furniture.
Source: MarketsandMarkets — Medical Devices Market, Global Forecast to 2031.
3. Europe's 2026 Medical Technology Report Tells a Different Growth Story
Global market forecasts are useful, but regional performance can be very different.
On October 6, 2026, MedTech Europe published its latest Facts & Figures report.
The results offer an important perspective on the industry's development.
Europe's medical technology market grew by 1.8% in 2025
MedTech Europe reports that European medical technology market growth slowed to 1.8% in 2025.
The organization's reported average annual growth over the preceding decade was approximately 5.6%.
This is a meaningful slowdown in the regional market.
It also illustrates why global growth forecasts should not be used to predict the performance of every individual country.
However, the European 1.8% figure and the global 7.1% CAGR should not be presented as directly comparable growth rates.
They describe different geographic scopes, time periods and research methodologies.
The global figure is forward-looking.
The European figure describes reported historical performance.
Europe's share of the global market declined
MedTech Europe states that the region's estimated share of the world medical technology market declined from 26.4% to 25.6%.
The same report identifies structural challenges associated with market access, regulatory complexity and the adoption of innovation.
A declining share does not necessarily mean the absolute size of Europe's market is shrinking.
A region can continue growing while accounting for a smaller proportion of a faster-growing global industry.
Europe has more than 950,000 medical technology employees
The report states that direct employment in Europe's medical technology sector exceeded 950,000.
This is important because the industry consists of far more than a handful of multinational corporations.
The wider manufacturing and supply ecosystem includes specialized companies serving different clinical and technical needs.
Hospitals purchasing equipment internationally must therefore evaluate suppliers on more than company size or brand familiarity.
Documentation, intended use, manufacturing quality, regulatory compliance, technical support and long-term service arrangements all matter.
Optium's analysis of why hospitals source electric beds from Turkey explores these supplier-selection considerations in a cross-border procurement context.
The country of manufacture alone does not prove a device's quality or suitability.
Innovation activity remains substantial
MedTech Europe also reports more than 15,900 European patent applications associated with medical technology in 2025.
Patent activity reflects technological development.
It does not establish that every patented invention will be commercially successful, clinically useful or widely adopted.
A patented device still requires appropriate assessment, implementation and ongoing support.
European investment priorities are changing
MedTech Europe emphasizes pressure on healthcare budgets, regulatory demands and growing attention to long-term value.
These challenges are highly relevant to hospital equipment procurement.
A purchase decision should consider the cost and practical consequences of getting equipment to the point where it can be used.
For international hospital projects, the initial unit price may be only one component of total investment.
Packaging, freight, customs, local transport and delivery arrangements can substantially change the final cost.
For instance, the Optium guide to 40HQ container capacity and landed hospital bed costs demonstrates why different packaging and loading configurations can affect the delivered price of otherwise comparable equipment.
What should hospitals learn from Europe's market slowdown?
Not that medical technology investment is unnecessary.
Nor that slower market growth automatically indicates declining healthcare quality.
Rather, the European findings reinforce three separate questions:
How much money is being spent on medical technology?
How efficiently is that technology adopted and maintained?
What clinical services does the investment ultimately support?
Each question requires different evidence.
Market growth alone cannot answer all three.
Sources: MedTech Europe — Facts & Figures 2026 and European Medical Technology Market Data.
4. What Is Actually Included in the Global Medical Devices Market?
The term medical device covers an extraordinarily broad range of products.
WHO estimates that approximately 2 million different kinds of medical devices are available on the world market.
They are grouped into more than 7,000 generic device categories.
These products can support diagnosis, monitoring, treatment, rehabilitation and other medical purposes.
They are used in hospitals, laboratories, ambulances, outpatient clinics and homes.
The MarketsandMarkets forecast includes major segments such as:
In vitro diagnostic devices
Cardiovascular devices
Diagnostic imaging equipment
Orthopedic devices
Endoscopy devices
Ophthalmology devices
Diabetes care devices
Wound care devices
Kidney and dialysis devices
Respiratory care devices
This wide scope is the first reason that the $818 billion figure must be interpreted carefully.
Are hospital beds medical devices?
Depending on their intended purpose and applicable regulatory framework, hospital beds can qualify as medical devices.
Under the European Union's Medical Device Regulation, the manufacturer's intended medical purpose is important in determining whether a product falls within the legal definition.
But regulatory classification and commercial market segmentation are separate questions.
A product may qualify as a regulated medical device without being included in a particular analyst's market category.
A market research report may also group several product types differently from another provider.
What about patient trolleys and hospital stretchers?
The distinction between a patient trolley, a transport stretcher and a specialized emergency stretcher is particularly relevant to healthcare purchasing.
Different products may support different combinations of mobility, positioning, treatment and patient transfer.
Optium's comparison of patient trolley vs. hospital stretcher explains why terminology should not replace an assessment of actual functions.
The regulatory and procurement classification of a particular product depends on its intended use and applicable requirements.
Do all hospitals need advanced medical equipment?
No.
A facility providing general inpatient care does not necessarily require the same technology portfolio as a tertiary hospital.
For example, comparing ICU beds with conventional hospital beds reveals how clinical acuity changes requirements for positioning, controls, patient access and supporting care.
Some departments may benefit from specialized capabilities.
Others may be better served by reliable equipment with a simpler configuration.
This also explains why a manual hospital bed buying guide remains relevant in an industry increasingly dominated by discussions of AI and automation.
A less complex device is not automatically an inferior purchasing decision.
The correct configuration is the one that satisfies the clinical requirements of its intended environment.
The growth of the medical devices market does not mean every hospital should buy the most sophisticated available equipment.
Source: WHO — Medical Devices and Regulation (EU) 2017/745.
5. Why Is Global Demand for Medical Devices Increasing?
The medical technology market is influenced by several long-term trends.
Their importance varies by product category, country and healthcare system.
The world's population is ageing
WHO projects that by 2030, one in six people worldwide will be aged 60 or older.
The population in this age group is expected to increase from approximately 1 billion in 2020 to 1.4 billion in 2030.
Population ageing can influence demand for chronic disease management, rehabilitation, mobility support and long-term care.
But it does not mean that every older person will require hospitalization.
Many older adults remain healthy, independent and active.
Hospitals should therefore use local population characteristics, disease burden and care utilization to determine equipment requirements.
For example, recovery and rehabilitation environments may need to review positioning, patient transfer and mobility support.
Optium's guide to electric hospital beds for post-operative recovery illustrates why patient acuity and recovery workflow should influence equipment selection.
Chronic diseases create continuing treatment needs
Chronic diseases can require repeated diagnostic examinations, monitoring and long-term treatment.
A major 2025 study published in The Lancet estimated that approximately 788 million adults aged 20 and older were living with chronic kidney disease in 2023.
This figure does not represent the number of people requiring dialysis.
Most individuals with chronic kidney disease do not need kidney replacement therapy at any given time.
Nevertheless, the scale of the disease illustrates the need for appropriate health service planning.
Our analysis of 788 million adults with kidney disease and the global dialysis access gap examines differences in treatment infrastructure and access.
It also demonstrates why disease prevalence cannot be translated directly into an equipment quantity.
A dialysis program requires more than machines and chairs.
It needs trained professionals, appropriate water treatment, maintenance, consumables, scheduling and clinical oversight.
Technology is becoming more sophisticated
Advances in connected devices, AI-assisted diagnostics, minimally invasive procedures, medical imaging and digital monitoring contribute to market growth.
Some technologies may extend clinical capabilities.
Others may improve efficiency or support earlier diagnosis.
However, technological sophistication is not a substitute for evidence of clinical value.
Advanced equipment can introduce additional software, maintenance, training, cybersecurity and infrastructure requirements.
The appropriate decision depends on the clinical problem being addressed.
Hospitals continue to modernize infrastructure
New facilities, specialist treatment units and renovation projects can increase equipment demand.
So can replacement of ageing devices.
A hospital does not need to expand the number of patient rooms to generate substantial procurement activity.
It may replace an existing bed fleet, modernize operating rooms or improve diagnostic capabilities.
But replacement should be linked to equipment condition and operational requirements rather than simply the age of the existing inventory.
Healthcare systems face patient-flow challenges
Equipment availability is only one element of hospital performance.
Delays in admissions, transfers and discharge can reduce the efficient use of available capacity.
Our analysis of 49,034 admissions and the association between emergency department boarding and hospital length of stay illustrates how capacity problems can extend beyond individual departments.
A hospital can own appropriate beds and still face operational bottlenecks.
The same principle applies throughout the medical technology market.
Demand for devices is growing, but clinical capacity depends on how those devices interact with the wider healthcare system.
6. OECD Research: More Diagnostic Equipment Does Not Automatically Mean More Appropriate Care
One of the strongest comparisons comes from the OECD's Health at a Glance 2025 report.
The OECD examines the availability and utilization of three major diagnostic technologies:
Computed tomography, or CT
Magnetic resonance imaging, or MRI
Positron emission tomography, or PET
These technologies are expensive and clinically important.
They provide a useful illustration of why medical equipment counts should not be interpreted as direct measures of healthcare quality.
Some countries have much more imaging equipment than others
The OECD reports that Japan has particularly high numbers of CT and MRI devices per capita.
Australia and the United States also rank highly for certain imaging equipment categories.
Other countries have significantly fewer devices relative to population.
These differences are meaningful for understanding access and infrastructure.
But they do not establish that the country with the most scanners necessarily delivers the best care.
Equipment availability and utilization are different indicators
The OECD also examines how frequently imaging technologies are used.
In 2023, combined CT, MRI and PET utilization exceeded 370 examinations per 1,000 population in countries including Luxembourg, Korea, Austria, France and Portugal.
Other countries recorded much lower examination rates.
The differences may reflect variations in healthcare delivery, clinical demand, referral practices, service organization and equipment distribution.
But a higher number of examinations is not automatically better.
The clinical appropriateness of each examination matters.
There is no universal ideal scanner count
The OECD notes that there is no generally accepted international benchmark for an ideal number of CT, MRI or PET devices.
Insufficient equipment may create access problems and delays.
Excessive availability or inappropriate use can generate costs without providing additional patient benefit.
Therefore, hospitals should not base purchasing decisions solely on equipment-per-population rankings.
Clinical appropriateness matters
The OECD cites research examining whether diagnostic imaging examinations were consistent with relevant clinical guidance.
One Swedish retrospective study assessed 13,075 CT and MRI examinations.
Approximately 76% of MRI examinations and 63% of CT examinations were classified as appropriate under the criteria used.
These results describe a specific study population and methodology.
They should not be generalized into global rates of inappropriate imaging.
Nevertheless, the study illustrates an important point:
A medical device can be available and frequently used without every instance of use necessarily being clinically appropriate.
Four questions behind equipment value
Hospitals evaluating diagnostic technology should distinguish:
Availability: Can the device be accessed when needed?
Utilization: How frequently is it used?
Appropriateness: Does its use match the patient's clinical needs?
Sustainability: Can the device be operated and maintained reliably?
The relative importance of these measures differs by equipment category.
But the broader lesson applies beyond imaging systems.
A well-managed medical equipment investment needs a clear purpose and a functioning clinical process.
Source: OECD — Health at a Glance 2025: Diagnostic Technologies.
7. WHO's 2026 Message: Buying a Device Is Not the Same as Keeping It Functional
In September 2026, WHO's Regional Office for South-East Asia published From Purchase to Functionality: Life-cycle Implementation of Medical Devices Including IVDs.
The publication emphasizes that access depends on devices remaining appropriate, safe, available and functional throughout their lifecycle.
The approach is particularly relevant to hospitals expanding or replacing equipment fleets.
Procurement is only the first stage
Purchasing creates ownership or access to an asset.
But additional processes may be necessary before that asset can be used.
Depending on the product, these may include:
Delivery inspection
Installation
Commissioning
Regulatory or technical verification
Compatibility checks
Staff training
Inventory registration
Preventive maintenance planning
Spare-parts arrangements
Operational handover
The precise requirements depend on the equipment.
A patient transport stretcher and a complex imaging system should not be managed through identical commissioning procedures.
Staffing is part of equipment readiness
Medical technology needs users with appropriate clinical and technical competencies.
The availability of those professionals can become a limiting factor.
Even when equipment is functioning, staffing constraints can affect when and how it is used.
The broader demands on nursing teams also depend on hospital design and workflow.
Optium's research on how far nurses walk during a twelve-hour shift explains why physical layouts and repeated movement deserve attention in hospital planning.
Equipment investments should seek to support clinical work rather than introduce unnecessary tasks.
Technology needs usable information
Connected devices can create more data and alerts.
But not all additional information is useful.
Monitoring systems must support clinically meaningful decisions.
Our analysis of hospital alarm fatigue and repeated medical device alerts illustrates why more technological signals do not automatically improve care.
Devices need to be integrated into processes that help staff identify and respond to important information.
Maintenance is part of healthcare delivery
WHO's 2025 publication on medical device inventory and maintenance reinforces the same lifecycle perspective.
Hospitals must know what equipment they own, its condition, its location and the maintenance it requires.
This information supports preventive maintenance, repair planning and replacement decisions.
Without reliable records, equipment purchasing can become disconnected from actual operational needs.
Five questions suggested by WHO's approach
Before making a new equipment investment, a hospital should ask:
Is the device appropriate for the intended clinical service?
Are the infrastructure and qualified users available?
Can it be installed, maintained and repaired?
Are the necessary consumables, accessories and spare parts obtainable?
How will the organization verify that the device remains functional over time?
These questions are an editorial synthesis of lifecycle management principles, not an official WHO checklist.
The central conclusion is simple.
A device does not deliver lasting healthcare value merely because it has been purchased.
Sources: WHO — From Purchase to Functionality, 2026 and WHO — Inventory and Maintenance Management Information System for Medical Devices, 2025.
8. Why 100 Purchased Hospital Beds May Not Mean 100 Usable Patient Positions
Hospital beds demonstrate the difference between physical equipment and operational healthcare capacity.
The OECD's Health at a Glance 2025 reports an average of 4.2 hospital beds per 1,000 population across OECD countries in 2023.
But hospital bed statistics depend on definitions.
The relevant international measure concerns maintained, staffed and available inpatient beds rather than simply every physical bed frame owned by a facility.
A hypothetical 100-position hospital
Imagine a hospital planning an expansion to 100 patient positions.
At a particular assessment date:
100 patient positions have been approved.
96 beds have been installed.
91 meet the relevant equipment readiness criteria.
78 can be supported by the available workforce and infrastructure.
72 meet all requirements for immediate use at that moment.
Under these deliberately simplified assumptions, the hospital has 72 ready patient positions.
This is a hypothetical example, not observed hospital data.
The remaining positions are not necessarily unavailable because their bed frames are defective.
Constraints may involve commissioning, accessories, staffing, supporting infrastructure or temporary service conditions.
That distinction is essential when interpreting procurement reports.
Bed occupancy does not measure equipment functionality
The OECD reports an average curative-care bed occupancy rate of approximately 72% among countries with comparable data in 2023.
This does not mean that 28% of hospital beds were defective or unstaffed.
Occupancy reflects service demand, admissions, length of stay and other factors.
It is also important for hospitals to maintain appropriate spare capacity.
There is no universally agreed optimal occupancy rate applicable to every hospital system.
The workforce changes the calculation
WHO's State of the World's Nursing 2025 estimated a global nursing workforce shortage of 5.8 million in 2023.
The projected shortage falls to 4.1 million by 2030 if current trends continue.
These are workforce shortage estimates against a population-based benchmark.
They are not counts of vacant hospital nursing positions.
Nevertheless, they demonstrate why workforce availability must be considered alongside clinical infrastructure.
Patient-flow capacity is also different from bed count
A hospital may have available beds but still experience delays because patients require different types of care.
For example, a patient waiting for an intensive care position cannot automatically be accommodated in any available general ward bed.
Clinical suitability matters.
Therefore, the number of patient positions is only one part of capacity planning.
Physical capacity, technically functional equipment, staffed capacity and clinically suitable capacity are not interchangeable.
Source: OECD — Hospital Beds and Occupancy.
9. Original Analysis: The Optium Investment-to-Care Framework
If medical equipment revenue does not measure clinical capacity, how should hospitals evaluate their investments?
We propose the Optium Investment-to-Care Framework.
This is an original editorial model designed to structure healthcare equipment procurement and readiness discussions.
It is not an official WHO framework, a clinically validated scoring instrument or a substitute for institutional accreditation requirements.
The model divides equipment investment into six stages.
Stage 1: Purchased equipment
What has the hospital acquired?
Relevant information may include quantities, configurations, acquisition costs, delivery dates and contractual requirements.
These measures establish the financial and procurement position.
They do not prove that equipment is usable.
Stage 2: Installed and accepted equipment
What has been delivered, checked and prepared for its intended use?
Depending on the product, this may require installation, functional inspection, commissioning, technical acceptance and user training.
A device should not be assumed to be ready simply because delivery is complete.
Stage 3: Functional equipment
Which assets meet their applicable operational and safety requirements?
Hospitals should distinguish working equipment from devices awaiting repair, inspection, maintenance or replacement.
Functionality must be evaluated against the device's intended purpose.
An electrically adjustable bed with an unresolved braking problem may not meet the full functional requirements for safe use.
Stage 4: Clinically ready equipment
Which functional assets can support an approved clinical service now?
Readiness may depend on staffing, accessories, consumables, infrastructure and the operating environment.
A dialysis chair can be functional even if the facility cannot operate the corresponding treatment station.
An ICU bed can be functional even when the hospital lacks the resources needed to provide intensive care at that position.
Stage 5: Delivered clinical services
What healthcare activities did the equipment support?
Possible measures include:
Completed treatment sessions
Clinically appropriate diagnostic examinations
Available staffed bed-days
Completed patient transfers
Other service-specific activity indicators
The indicators must fit the clinical context.
More procedures or treatments are not automatically better if they are unnecessary.
Stage 6: Patient-centered value
Did the service help achieve its intended healthcare objective?
Relevant outcomes may involve access, safety, timeliness, treatment effectiveness, continuity of care and patient experience.
Attribution requires caution.
Clinical outcomes depend on many factors beyond individual medical devices.
A single bed or stretcher should not be credited with a clinical benefit without appropriate evidence.
Why this framework is useful
The framework separates three questions often combined in procurement reporting.
What did we buy?
What can we reliably use?
What healthcare can we actually deliver?
The gap between these answers can identify where an equipment project needs attention.
Sometimes the solution is additional purchasing.
Sometimes it is repair, training, asset redistribution, better service planning or supporting infrastructure.
The framework does not predetermine which intervention is correct.
It helps structure the investigation.
10. Four Metrics for Measuring Medical Equipment Readiness
A practical management framework requires clearly defined indicators.
Different clinical devices require different measurements.
Nevertheless, four metrics can provide a useful starting point.
Functionality rate
Functional assessed assets ÷ applicable assessed assets × 100
Imagine a hospital assessing 200 devices in a defined category.
If 184 meet the required functional criteria, the measured functionality rate is 92%.
This is a hypothetical example.
The functional criteria should be specific to the equipment type.
Ready-for-use rate
Assets meeting immediate-use requirements ÷ applicable assets × 100
This measure adds operational requirements to technical condition.
The organization must clearly define the status of equipment already serving patients.
An asset actively supporting care should not automatically be treated like an asset unavailable because of a fault.
Unplanned downtime
Track the time equipment is unable to perform its intended function because of an unexpected problem.
Categorize causes where practical.
A device awaiting a replacement part differs from a device temporarily allocated to another department.
Delivered clinical activity
Measure the appropriate clinical services supported by the equipment.
A dialysis unit may evaluate completed treatment sessions.
A ward may examine available staffed bed-days.
An imaging service may assess clinically appropriate examinations and access times.
Patient transport services may combine transfer activity with safety and reliability indicators.
The goal is not to maximize every utilization number.
It is to understand whether the equipment is available and supporting appropriate care.
A useful equipment dashboard separates inventory, functionality, readiness and service delivery.
11. Hospital Beds: Choosing the Correct Level of Technology
The medical devices industry's growth includes increasingly sophisticated equipment.
But hospital purchasing should begin with clinical requirements rather than the newest available features.
Different departments need different bed configurations.
Why hospital bed standardization can fail
Standardization can simplify training, spare-parts inventories and maintenance.
But it can also create problems when a hospital selects one universal model for departments with very different needs.
Optium's research on hospital bed standardization and the risk of buying the same bed for every ward examines that trade-off.
A general ward does not necessarily require every feature of an intensive care bed.
An ICU should not be forced to use an inadequately specified bed simply to reduce model variation.
Motor count is not the entire specification
It is tempting to rank beds according to motor count.
However, the number of motors does not independently define clinical suitability.
What matters is which movements are powered, how they are controlled and whether those capabilities support the intended patient population.
The comparison of 3-motor versus 4-motor hospital beds explains why buyers should examine actual functions rather than marketing shorthand.
General patient care: CL 32
The Optium CL 32 electronic patient care bed includes electrical adjustment of the backrest, legrest and height, along with other manufacturer-specified positioning and safety features.
This illustrates one configuration that can be assessed for general patient-care requirements.
It does not establish that the model is universally appropriate for every ward.
Higher-acuity care: CL 43
The Optium CL 43 electronic ICU bed includes a different set of positioning and control features intended for intensive care applications.
Its published specifications identify nurse controls, electrical functions and emergency positioning capabilities.
These features must be evaluated against the actual operating environment.
They do not independently demonstrate reduced mortality or other clinical outcomes.
The mattress must fit the bed and the patient
A bed frame alone is not a complete patient-support system.
Mattress dimensions, thickness, compatibility, pressure redistribution and cleaning requirements matter.
Optium's hospital mattress selection guide for pressure injury prevention explains why equipment selection should consider the bed, mattress, patient and care protocol together.
Safety extends beyond the purchase specification
Patient safety depends on equipment condition and clinical practice.
For example, brakes, height, barriers, patient mobility and staff supervision can all affect fall-related risks.
The research on patient falls and hospital bed safety provides context for evaluating the interaction between equipment and care processes.
Similarly, cleanability is part of lifecycle suitability.
Hospital beds have high-touch surfaces that require appropriate cleaning and disinfection.
Our article on how long germs can survive on hospital bed surfaces examines why rails, controls, mattress covers and frequently handled components matter.
Technology should support mobility and care
More advanced beds can offer functions relevant to patient positioning and mobility.
But the clinical objective should be defined first.
The Optium analysis of early mobility and ICU bed design explores how hospital bed capabilities may support broader care processes without replacing clinical protocols.
The right hospital bed is not necessarily the most advanced one. It is the one appropriately matched to the department, patient population and clinical workflow.
12. Patient Transport: Equipment Is Only One Part of Safety
Transport stretchers are another example of how medical equipment functions within a larger system.
Moving a patient can require coordination between departments, clinical monitoring, suitable equipment and trained personnel.
A hospital may invest heavily in imaging or surgical technology while paying insufficient attention to the processes required to bring patients safely to those services.
What research says about intrahospital transport
A 2022 systematic review and meta-analysis by Murata and colleagues, published in the American Journal of Emergency Medicine, examined 12,313 intrahospital transports involving 1,898 critically ill patients across 24 studies.
The researchers estimated a pooled adverse-event frequency of 26.2% (95% CI: 15.0–39.2%).
However, the studies showed exceptionally high heterogeneity (I² = 99.5%), meaning the pooled figure should not be interpreted as a universal hospital transport complication rate.
It also does not mean that one in four patients suffered an injury.
Nor does the study demonstrate that stretcher design caused the observed events.
Our detailed research on 12,313 ICU transports and patient safety examines the findings, definitions and limitations.
The broader lesson is that patient transport involves clinical, technical and organizational risks that require coordinated management.
Emergency transport: EMERGEUM
The Optium EMERGEUM emergency stretcher includes hydraulic height adjustment, central braking, a fifth wheel and features supporting certain X-ray workflows, according to the manufacturer's specifications.
These capabilities may be relevant to emergency and trauma environments.
However, no specific reduction in transport adverse events can be inferred from the feature list alone.
Routine transport: ST 62
The Optium ST 62 hydraulic patient stretcher has a different equipment configuration, including hydraulic height adjustment and gas-spring-assisted backrest positioning.
Some features are optional.
Procurement teams must confirm the precise supplied configuration.
The decision should depend on the intended patient transport tasks, rather than assuming every department needs an emergency-grade stretcher.
Imaging compatibility matters
A radiotransparent platform may allow certain radiographic examinations without moving the patient to another support surface.
But radiotransparency does not automatically mean CT or MRI compatibility.
The X-ray-compatible hospital stretcher guide explains why buyers must verify the exact imaging requirements.
The correct purchasing question
Rather than asking only which stretcher has the most features, hospitals should examine:
Where patients will travel
Which clinical equipment accompanies them
Whether transfer between surfaces is required
How the destination is prepared
Which accessories are needed
What maintenance the stretcher will require
Whether the equipment fits real corridors, doors and elevators
Transport equipment should be selected around the entire patient journey, not merely its movement capabilities.
13. Dialysis: Treatment Chairs Are Not Treatment Capacity
Chronic kidney disease and the growing demand for specialist care make dialysis infrastructure an important component of healthcare planning.
However, dialysis treatment capacity is not determined by the number of chairs alone.
It requires an appropriate clinical environment.
A hypothetical twelve-station dialysis center
Imagine a facility with twelve dialysis stations.
For illustration, assume each station is scheduled for two sessions per day and the center operates six days each week.
The theoretical weekly schedule is:
12 stations × 2 sessions × 6 days = 144 treatment sessions.
This is a hypothetical capacity calculation, not a clinical scheduling recommendation.
If two stations are unavailable for the entire week:
10 stations × 2 sessions × 6 days = 120 theoretical sessions.
The difference is 24 potential session slots.
Actual treatment delivery can be affected by staffing, clinical protocols, patient characteristics, maintenance and other operational factors.
The number of sessions is not the same as the number of unique patients.
Selecting treatment chairs
The Optium dialysis chair buying guide discusses positioning, clinical access, patient support, hygiene and maintenance requirements.
These considerations matter because the chair is part of a long-duration treatment environment.
Example: Optium DC 44
The Optium DC 44 electrical dialysis and chemotherapy chair includes powered adjustment of backrest, legrest, height and Trendelenburg positioning.
Those are manufacturer-published features.
They should be evaluated for intended use and compatibility with the treatment environment.
They do not independently prove that a dialysis center can deliver more treatment sessions or achieve better clinical outcomes.
More treatment furniture can support expansion, but it cannot replace the workforce, infrastructure and clinical systems required to deliver care.
14. Specialized Clinical Equipment Must Match the Workflow
The same principle applies to operating-room transfers and other specialized hospital environments.
An operating-room transfer system may need to support movement between areas with different hygiene controls and clinical responsibilities.
This creates requirements that differ from routine ward transport.
Example: Optium OT TRANS
The Optium OT TRANS operating-room transfer stretcher uses separate stainless steel chassis for clean and non-clean areas, together with a sliding patient-support platform.
Its suitability depends on the facility's operating-room design and approved transfer procedures.
A product should not be considered appropriate solely because its materials or appearance seem suitable for a clinical environment.
Intended use, cleaning requirements, patient handling, serviceability and workflow integration all matter.
This approach applies equally to stainless steel scrub units, medical workstations and other specialized furnishing systems.
The function of equipment must be evaluated within the process it supports.
15. Why the Cheapest Medical Equipment Can Become a More Expensive Investment
The global medical devices market measures commercial value.
Hospitals, however, must consider the costs of acquiring and operating equipment.
The total cost of ownership may include:
Acquisition price
Delivery and installation
Commissioning
Training
Maintenance
Repairs
Spare parts
Cleaning and consumables
Technical support
Downtime
Replacement or decommissioning
These cost categories vary by product.
An illustrative five-year calculation
Consider two hypothetical hospital stretcher offers.
Offer A
Purchase price: $2,300.
Annual maintenance: $350.
Annual spare-parts allowance: $150.
Five-year modeled total:
$2,300 + 5 × ($350 + $150) = $4,800.
Offer B
Purchase price: $2,700.
Annual maintenance: $200.
Annual spare-parts allowance: $120.
Five-year modeled total:
$2,700 + 5 × ($200 + $120) = $4,300.
Under these assumptions, Offer B has a higher purchase price but a lower five-year modeled total.
These are illustrative values, not real supplier quotations or observed performance data.
The example excludes additional potential costs such as freight, taxes, financing, downtime and staffing.
The calculation demonstrates only that initial purchase price and lifecycle cost can produce different rankings.
More expensive does not automatically mean better
A premium device may offer clinically necessary functions.
But a simpler product may also provide excellent value when the required capabilities are less demanding.
The comparison of $500 and $5,000 hospital beds shows why different equipment configurations should not be compared as though they were identical.
The hospital needs to understand what functions, support and lifecycle obligations are included in each offer.
New versus refurbished equipment
Refurbished equipment may appear financially attractive.
But age, maintenance history, parts availability and remaining service life can change its total value.
Our new versus refurbished hospital bed analysis examines these issues in a purchasing context.
The correct decision depends on condition, clinical suitability, documentation and lifecycle expectations.
Technical specifications determine whether offers are comparable
A supplier may include mattresses, batteries, centralized brakes, training and maintenance support.
Another supplier may quote those items separately.
The lowest line-item price may therefore reflect a smaller scope.
Optium's 50 hospital bed tender requirements explains why buyers should define exactly what is being purchased.
The objective is to compare equivalent requirements.
The lowest quotation and the lowest defensible total cost are not necessarily the same thing.
16. Five Procurement Mistakes That Reduce Medical Equipment Value
Mistake 1: Selecting technology before defining the clinical need
A hospital should begin with the service it needs to provide.
Only then should it determine equipment functions and configurations.
Starting with a product brochure can encourage unnecessary features or overlook essential requirements.
Mistake 2: Ignoring the real physical environment
A hospital bed's mattress platform dimensions are not the same as its total footprint.
Likewise, a stretcher's width does not establish whether it can navigate every corridor turn.
The seven hospital bed dimensions buyers must check explains why room layouts, access requirements and logistics dimensions should be evaluated separately.
Mistake 3: Assuming a listed feature guarantees operational readiness
A device may advertise battery backup, but the actual supported functions and operating conditions must be verified.
The hospital bed backup battery guide illustrates why the presence of a battery alone is insufficient to determine performance during a power interruption.
Mistake 4: Neglecting maintenance and after-sales support
A device can meet its initial specifications but become unavailable when spare parts or qualified technical support are difficult to obtain.
Hospitals should review maintenance documentation, inspection requirements, parts availability and service arrangements before purchase.
Mistake 5: Declaring success when delivery is complete
Delivery is an important project milestone.
It is not equivalent to clinical readiness.
Hospitals should document installation, acceptance, functionality and operational availability as separate stages where appropriate.
This distinction helps procurement, finance, clinical teams and biomedical engineering evaluate the same investment consistently.
17. Twelve Questions Every Hospital Should Ask Before Its Next Equipment Investment
The following checklist is an original Optium editorial synthesis.
It is intended to support procurement discussions, not replace institution-specific clinical, regulatory or engineering requirements.
Clinical requirements
1. What clinical service will this equipment support?
Define the intended use clearly.
2. What evidence shows that additional equipment is necessary?
Consider demand, existing asset condition and operational constraints.
3. Is the proposed configuration appropriate for the intended department?
Do not equate greater technical complexity with greater suitability.
Installation and infrastructure
4. Is the necessary infrastructure available?
Review power, medical gases, water, space, network and other relevant dependencies.
5. Who will install, inspect and commission the equipment?
Define responsibilities before delivery.
6. Are compatible accessories and consumables available?
The main device may depend on supporting equipment.
Clinical use
7. Are qualified professionals available to use it?
Training and staffing should be addressed in the operational plan.
8. Does the device integrate with existing care workflows?
Examine movement, positioning, patient access and interaction with other systems.
Lifecycle
9. What maintenance will the device require?
Consider preventive maintenance, inspections, repairs and technical support.
10. What is the estimated total cost of ownership?
Use realistic, comparable assumptions.
Measurement
11. How will the hospital measure functionality and availability?
Define equipment-specific indicators.
12. How will the organization determine whether the investment achieved its purpose?
Identify appropriate service and outcome measures.
A checklist does not guarantee successful procurement.
It helps decision-makers identify essential questions before committing resources.
18. An Original 90-Day Equipment Readiness Review
A hospital does not need to wait for its next major purchasing cycle to improve equipment management.
The following 90-day approach provides a practical starting point.
It is an editorial management model, not a clinically validated protocol or official WHO implementation schedule.
Days 1–30: Establish the current inventory
Begin by identifying important equipment categories.
Record:
Equipment type and configuration
Department and location
Intended clinical use
Technical status
Maintenance responsibilities
Relevant accessories
Commissioning status
Availability for approved use
Separate functional equipment from assets awaiting repair, inspection or acceptance.
Avoid categorizing every temporarily unavailable item as defective.
Days 31–60: Identify the largest readiness constraints
Review recurring problems.
Which devices experience repeated downtime?
Are spare parts difficult to obtain?
Is equipment poorly distributed?
Are some departments using products that do not suit their workflows?
Are clinical services restricted by workforce or infrastructure constraints rather than missing equipment?
Classify issues by likely cause.
The goal is to understand which constraints can be addressed through maintenance, redistribution, training or better planning and which genuinely require new purchases.
Days 61–90: Test targeted improvements
Select a manageable set of interventions.
Possible actions include:
Revising acceptance procedures
Improving preventive maintenance scheduling
Clarifying asset allocation responsibilities
Updating equipment specifications
Improving spare-parts planning
Standardizing compatible components where appropriate
Refining equipment status reporting
Measure the outcomes relevant to each intervention.
Look for unintended consequences.
Do not claim that patient outcomes improved without collecting appropriate evidence.
What happens after 90 days?
The hospital should have a clearer view of equipment condition, availability and investment priorities.
The process can then become part of ongoing equipment management.
The goal is not necessarily to purchase fewer devices.
A readiness review may demonstrate that additional investment is urgently needed.
Alternatively, it may identify existing equipment that can be restored, reassigned or used more effectively.
The best procurement decision is the one supported by evidence of clinical need and operational readiness.
19. What the $818 Billion Forecast Cannot Tell Us
The global market estimate is useful.
But it has important limitations.
It does not measure the hospital furniture market specifically
The forecast includes numerous medical device segments.
It should not be represented as the projected market size for hospital beds, stretchers or treatment chairs alone.
It does not reveal how many individual devices will be purchased
Revenue can increase through pricing changes, product mix, technology development and other factors.
Market value is different from unit volume.
It does not establish equipment functionality
The forecast does not report whether existing devices are operational or available when needed.
That requires operational data.
It does not directly measure patient access
A market can grow while some populations continue facing geographical, financial or infrastructure barriers.
Access must be assessed through relevant healthcare indicators.
It does not demonstrate better clinical outcomes
The existence or cost of medical technology cannot independently establish its clinical effectiveness.
Patient outcomes require appropriate evidence.
It does not imply equal growth across countries
Regional markets differ.
MedTech Europe's 2026 findings demonstrate why a single global growth rate should not be applied automatically to Europe or individual countries.
It does not establish an ideal equipment quantity
The OECD's diagnostic technology research shows why both insufficient capacity and inappropriate overuse are important.
There is no universal equipment count suitable for every healthcare system.
It is a forecast, not a guarantee
The 2031 figure reflects one research provider's assumptions and methodology.
Other analysts may define the market differently and produce different estimates.
Actual future results may vary.
Industry forecasts are valuable for understanding market direction. They are not substitutes for local clinical needs assessments.
20. Frequently Asked Questions About the Medical Devices Market
How big is the medical devices market in 2026?
MarketsandMarkets projects a global medical devices market value of $580.79 billion in 2026.
This is a report-based estimate or forecast rather than a definitive total accepted by every research provider.
What is the projected medical devices market size in 2031?
MarketsandMarkets forecasts approximately $817.78 billion by 2031, commonly rounded to $818 billion.
What is the expected medical devices market growth rate?
The report estimates a compound annual growth rate of 7.1% for 2026–2031.
Growth will vary by market segment and geography.
How much could the market grow between 2026 and 2031?
The difference between the forecast annual market values is $236.99 billion, approximately 40.8% of the 2026 value.
That is not cumulative spending across the period.
Why is the medical devices market growing?
Market growth drivers include population ageing, chronic disease, medical innovation, diagnostic demand and healthcare infrastructure development.
Their relative importance differs across product categories and countries.
How fast is Europe's medical technology market growing?
MedTech Europe's October 2026 report states that the European market grew by 1.8% in 2025, compared with a reported ten-year average of approximately 5.6%.
That historical regional figure should not be treated as directly equivalent to the global forecast CAGR.
Does a bigger medical devices market mean better healthcare?
Not necessarily.
Medical technology investment can support healthcare improvement, but clinical benefit depends on appropriate use, staffing, infrastructure, maintenance and access.
How many medical device types exist worldwide?
WHO estimates that around 2 million different kinds of medical devices exist globally, grouped into more than 7,000 generic device categories.
Are hospital beds considered medical devices?
They can be, depending on their intended medical purpose and applicable regulatory framework.
Their inclusion in a particular commercial market forecast is a separate question.
Are dialysis chairs included in the $818 billion market forecast?
The market research covers kidney and dialysis devices, but the precise treatment of individual product categories such as treatment chairs depends on the report's segmentation.
It should not be assumed without reviewing the scope.
Do more hospital beds always increase hospital capacity?
No.
Clinical capacity depends on whether appropriate patient positions are staffed, equipped, supported and available for use.
Do more CT and MRI scanners guarantee better diagnostic care?
No.
The OECD emphasizes the need to assess access, utilization and clinical appropriateness.
What is medical equipment lifecycle management?
It covers activities such as needs assessment, acquisition, installation, inventory, training, maintenance, performance monitoring and eventual replacement or decommissioning.
How can hospitals improve medical equipment availability?
Approaches may include inventory management, preventive maintenance, spare-parts planning, appropriate staff training, asset allocation and equipment-specific readiness monitoring.
The appropriate interventions depend on local conditions.
What is the difference between equipment functionality and clinical readiness?
Functionality concerns whether the device meets its defined operational and safety requirements.
Clinical readiness also considers whether the surrounding personnel, infrastructure and supporting resources are available for appropriate use.
How should hospitals evaluate medical equipment suppliers?
They should compare clinically suitable configurations, technical documentation, regulatory requirements, service arrangements, spare parts, warranty, lifecycle costs and operational compatibility.
Initial price alone is insufficient.
21. Conclusion: The Most Important Number Is Not $818 Billion
The global medical devices market could approach $818 billion by 2031.
That is a remarkable financial forecast.
It reflects the enormous economic scale of technologies used to diagnose, monitor and treat patients.
But market growth and healthcare improvement are not interchangeable.
MedTech Europe's 2026 findings reveal that regional growth can differ substantially from global projections.
The OECD demonstrates why equipment availability and actual utilization must be examined separately.
WHO's latest lifecycle guidance emphasizes the importance of keeping medical devices safe, functional and appropriate throughout their working lives.
Together, these findings support a more useful approach to hospital equipment investment.
A hospital does not become more capable simply because its equipment budget increases.
It becomes more capable when appropriate equipment is available within a system that can use it safely, effectively and sustainably.
For a patient bed, that means more than an adjustable frame.
For a stretcher, it means more than wheels and brakes.
For a dialysis chair, it means more than a treatment station.
Each product belongs to a larger clinical process.
The right purchasing decision recognizes that relationship.
As the medical devices industry approaches its projected 2031 milestone, hospital leaders face a question more important than the total revenue of the global market.
Not how much equipment can we buy, but how much appropriate, safe and reliable healthcare can we deliver with it?
That is the difference between a growing medical technology industry and a healthcare system that genuinely becomes more capable.
Research Methodology and Editorial Transparency
Research reviewed: October 2026.
This article was prepared as an Optium Healthcare editorial analysis for hospital managers, healthcare procurement teams, biomedical engineers, facility planners and distributors.
It combines publicly available market research, WHO guidance, OECD indicators, peer-reviewed research and manufacturer-published product specifications.
It is not an independently commissioned market forecast, a clinical trial, a systematic review or a validated healthcare performance instrument.
Market research
The 2025, 2026 and 2031 global medical devices market figures come from MarketsandMarkets' July 2026 report.
The $236.99 billion increase and approximately 40.8% growth are arithmetic calculations using the forecast endpoints.
They do not represent separate estimates of hospital investment.
European market data
MedTech Europe's Facts & Figures 2026 provides the historical European growth rates, global market share and industry indicators.
The MedTech Europe and MarketsandMarkets figures have different geographic scopes, reporting periods and potentially different market definitions.
They should not be treated as a single directly comparable statistical series.
OECD research
OECD's Health at a Glance 2025 provides comparative data on diagnostic technologies, hospital beds and occupancy.
The diagnostic appropriateness findings discussed in this article come from a specific study cited by the OECD.
They are not universal estimates of inappropriate diagnostic imaging.
WHO guidance
WHO's 2025 inventory and maintenance publication and September 2026 lifecycle implementation briefing inform the discussion of equipment functionality.
WHO's nursing workforce and population ageing estimates are used as additional healthcare-system context.
The global nursing shortage estimate is not a direct count of vacant hospital jobs.
Peer-reviewed clinical research
The estimate of 788 million adults living with chronic kidney disease in 2023 is drawn from a 2025 study published in The Lancet.
It is not an estimate of the global population requiring dialysis.
The findings on 12,313 intrahospital transports come from Murata and colleagues' 2022 systematic review and meta-analysis in the American Journal of Emergency Medicine.
Its pooled adverse-event frequency should not be interpreted as a universal risk of patient injury.
Original editorial analysis
The Investment-to-Care Framework, 100-position hospital illustration, dialysis capacity calculation, five-year lifecycle cost comparison, twelve-question checklist and 90-day readiness review are editorial examples.
They are not official WHO frameworks, independently validated clinical protocols or observed results from specific hospitals.
The hypothetical figures should not be used as universal clinical or financial benchmarks.
Commercial transparency
Optium Healthcare manufactures hospital furniture and medical equipment referenced in this article.
Descriptions of individual Optium products use manufacturer-published specifications.
These descriptions do not constitute independent proof of improved patient outcomes, reduced adverse events or superior lifetime cost.
Healthcare organizations should verify current technical documentation, options, applicable regulations and suitability for their intended use.
Primary Research Sources
1. MarketsandMarkets — Medical Devices Market: Global Forecast to 2031
Published July 2026.
https://www.marketsandmarkets.com/Market-Reports/top-10-medical-device-technologies-96.html
2. MedTech Europe — Facts & Figures 2026
Published October 6, 2026.
https://www.medtecheurope.org/resource-library/medtech-europes-facts-figures-2026/
3. MedTech Europe — European Medical Technology Market Data
https://www.medtecheurope.org/datahub/market/
4. World Health Organization — From Purchase to Functionality: Life-cycle Implementation of Medical Devices Including IVDs
Published September 4, 2026.
5. World Health Organization — Inventory and Maintenance Management Information System for Medical Devices
Published June 4, 2025.
https://www.who.int/publications/i/item/9789240111257
6. OECD — Health at a Glance 2025: Diagnostic Technologies
Published November 13, 2025.
7. OECD — Health at a Glance 2025: Hospital Beds and Occupancy
Published November 13, 2025.
8. World Health Organization — State of the World's Nursing Report 2025
Published May 12, 2025.
https://www.who.int/publications/i/item/9789240110236
9. World Health Organization — Ageing and Health
https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
10. World Health Organization — Medical Devices
https://www.who.int/health-topics/medical-devices
11. European Union — Regulation (EU) 2017/745 on Medical Devices
https://eur-lex.europa.eu/eli/reg/2017/745/2023-03-20/eng
12. GBD 2023 Chronic Kidney Disease Collaborators — Global, Regional, and National Burden of Chronic Kidney Disease in Adults, 1990–2023, and Its Attributable Risk Factors
The Lancet, 2025.
https://doi.org/10.1016/S0140-6736(25)01853-7
13. Murata et al. — Adverse Events During Intrahospital Transport of Critically Ill Patients: A Systematic Review and Meta-analysis
American Journal of Emergency Medicine, 2022.